Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
2018 · The Lancet Neurology · 177 citations
https://doi.org/10.1016/s1474-4422(18)30319-3
Showa University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
179
Citations
2
h-index
1
i10-index
K Ryota is an academic researcher from Showa University. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Bone health and osteoporosis research & Coronary Interventions and Diagnostics. The author has an h-index of 2, co-authored 3 publications.
Click to start Chat